Form 4 for IQV IQVIA
Accepted 2026-07-31 17:02:07 ET · period of report 2026-07-29 · accession 0001628280-26-051449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-31 17:02 | 2026-07-29 | IQV | BOUSBIB ARI | See Remarks, Dir | M - OptEx | $78.21 | +156.2K | 992.1K | +19% | +$12.22M |
| DM | 2026-07-31 17:02 | 2026-07-29 | IQV | BOUSBIB ARI | See Remarks, Dir | S - Sale+OE | $245.51 | -106.3K | 885.9K | -11% | -$26.09M |
| DM | 2026-07-31 17:02 | 2026-07-29 | IQV | BOUSBIB ARI | See Remarks, Dir | D - Sale to Iss | $244.70 | -49.9K | 835.9K | -6% | -$12.22M |
| D | 2026-07-31 17:02 | 2026-07-29 | IQV | BOUSBIB ARI | See Remarks, Dir | M - OptEx | $78.21 | -156.2K | 0 | -100% | -$12.22M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-29 | M | A | 156,206 | $78.21 | 992,147 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2027. |
| 2 | Common | Common Stock | 2026-07-29 | S | D | 4,465 | $247.10 | 987,682 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2027. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.00 to $247.18, inclusive. |
| 3 | Common | Common Stock | 2026-07-29 | S | D | 4,584 | $246.85 | 983,098 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2027. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.70 to $247.05, inclusive. |
| 4 | Common | Common Stock | 2026-07-29 | S | D | 44,039 | $246.08 | 939,059 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2027. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.58, inclusive. |
| 5 | Common | Common Stock | 2026-07-29 | S | D | 53,191 | $244.78 | 885,868 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2027. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.60 to $245.60, inclusive. |
| 6 | Common | Common Stock | 2026-07-29 | D | D | 47,858 | $244.60 | 838,010 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2027. |
| 7 | Common | Common Stock | 2026-07-29 | D | D | 2,069 | $247.00 | 835,941 | D | — | — | (F1) Represents the exercise of stock appreciation rights expiring on February 2, 2027. |
| 8 | Derivative | Stock Appreciation Right | 2026-07-29 | M | D | 156,206 | $78.21 | 0 | D | $78.21 · 2020-02-02 to 2027-02-02 | 156,206 Common Stock |